Ion Membrane Supplier's Disclaimer
Background Information (Legal Action)
Due to the potential for harm caused by toxic industrial-use perfluorinated compounds (PFAS), there have been multiple international medical lawsuits with total compensation claims potentially exceeding $10 billion.
During the COVID-19 pandemic, some appliance manufacturers—whether informed or not—incorporated this potentially harmful and toxic material into a core component of their devices: the water electrolysis cell.
In line with their corporate social responsibility and ethical obligations, a major international company has issued this disclaimer to urge all parties to prioritize and protect the health and safety of consumers.
Asclepius’ Innovation vs. Market Disorder
In the early stages of the COVID-19 pandemic in 2020, there was a global shortage of ventilators and oxygen generators. It was at this critical time that the Asclepius Hydrogen-Oxygen Mixed Gas Generator, a Class III medical device with a decade of unique water electrolysis technology designed for human safety, was approved by the China National Medical Products Administration (NMPA) to treat COVID-19 patients.
The massive market demand quickly led to manufacturers of industrial-grade hydrogen equipment—such as those used for hydrogen energy, combustion engines, metal welding, and automotive decarbonization—to start producing imitation medical devices for human inhalation. These products have not undergone the rigorous testing required for Class III medical devices and have already led to various reported adverse events in different countries.
Disclaimer from a Leading International Chemical Company
In response to these market irregularities, a major global chemical company has issued a formal disclaimer:
"Do not use PFSA membranes (including N-112, 115, 117, NE-1135, 1110 perfluorosulfonic acid polymer) in medical applications involving implantation in the human body or contact with internal body fluids or tissues. "
Notable Incidents
- Japan Case (March 2021)
According to a report by the Japanese newspaper Asahi Shimbun, an employee at a cosmetics company in Tokyo was involved in a fatal accident while attempting to replicate a hydrogen-oxygen device. The incident resulted in an explosion, causing one death and one severe injury.
- China Case (March 2023)
In Changsha, Hunan, China, an elderly patient died of an unknown cause after using a hydrogen-oxygen machine that had not been approved for market release by China's National Medical Products Administration (NMPA).
